Uric Acid and Clinical Outcomes Among Intracerebral Hemorrhage Patients: Results From the China Stroke Center Alliance.

Xinmin Liu, Zhentang Cao, Hongqiu Gu, Kaixuan Yang, Ruijun Ji, Zixiao Li, Xingquan Zhao, Yongjun Wang
Author Information
  1. Xinmin Liu: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  2. Zhentang Cao: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  3. Hongqiu Gu: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  4. Kaixuan Yang: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  5. Ruijun Ji: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  6. Zixiao Li: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  7. Xingquan Zhao: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  8. Yongjun Wang: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Abstract

The effect of uric acid (UA) levels on severity and prognosis of spontaneous intracerebral hemorrhage (ICH) remains controversial. We aimed to explore the association of admission UA levels with stroke severity and outcomes in ICH patients. The patients enrolled in this study were from the China Stroke Center Alliance study (CSCA). Patients were divided into four groups (Q1-Q4) according to the quartiles of UA levels at admission. The primary outcome was in-hospital mortality. The secondary outcomes included stroke severity, in-hospital complications, and discharge disposition. Multivariate logistic regression was adopted to explore the association of UA levels with outcomes after ICH. Patients (84,304) with acute ICH were included in the final analysis; the median (interquartile range) of UA was 277 (210, 354) μmol/L. The four groups were defined as follows: Q1 ≤ 210 μmol/L, 210 μmol/L < Q2 ≤ 277 μmol/L, 277 μmol/L < Q3 ≤ 354 μmol/L, Q4 > 354 μmol/L. There was no significant evidence indicating that UA levels were correlated with the discharge disposition and in-hospital mortality after ICH. However, compared to Q1, the patients with higher UA levels had decreased odds of severe stroke (NIHSS ≥ 16) at admission (OR 0.89, 95% CI 0.86-0.92). An L-shaped association was found between UA and severe stroke. Among in-hospital complications, decrease in pneumonia, poor swallow function, gastrointestinal bleeding, and deep vein thrombosis (DVT) were significantly associated with higher UA levels compared to Q1 ( < 0.0001). UA was a protective factor for stroke severity and in-hospital complications such as pneumonia, poor swallow function, gastrointestinal bleeding, and DVT. However, no significant evidence indicated that UA levels were predictive of the discharge disposition and in-hospital mortality after ICH.

Keywords

References

  1. Med Hypotheses. 2004;62(2):173-6 [PMID: 14962621]
  2. Lancet Neurol. 2014 May;13(5):453-60 [PMID: 24703208]
  3. Stroke Vasc Neurol. 2018 Sep 8;3(4):256-262 [PMID: 30637133]
  4. Pediatrics. 2013 Jul;132(1):e93-9 [PMID: 23776119]
  5. J Neurosci Res. 1998 Sep 1;53(5):613-25 [PMID: 9726432]
  6. J Mol Neurosci. 2020 Jan;70(1):94-101 [PMID: 31486972]
  7. BMC Neurol. 2017 Feb 1;17(1):21 [PMID: 28143422]
  8. J Am Soc Nephrol. 2007 May;18(5):1516-24 [PMID: 17409313]
  9. J Stroke Cerebrovasc Dis. 2014 Mar;23(3):469-75 [PMID: 23735371]
  10. Gut Liver. 2016 Mar;10(2):244-9 [PMID: 26087793]
  11. Sci Rep. 2016 May 27;6:26541 [PMID: 27231197]
  12. Int J Neurosci. 2009;119(12):2243-9 [PMID: 19916852]
  13. N Engl J Med. 2008 Oct 23;359(17):1811-21 [PMID: 18946066]
  14. JAMA. 2014 Jul 16;312(3):259-68 [PMID: 25027141]
  15. Clin Chem Lab Med. 2010 Mar;48(3):383-90 [PMID: 20020821]
  16. Pan Afr Med J. 2019 Apr 09;32:165 [PMID: 31303934]
  17. Neuroepidemiology. 2020;54(2):171-179 [PMID: 32079017]
  18. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6858-62 [PMID: 6947260]
  19. Stroke. 2016 Nov;47(11):2874-2876 [PMID: 27758945]
  20. Biochem J. 1986 May 1;235(3):747-54 [PMID: 3753442]
  21. J Stroke Cerebrovasc Dis. 2019 May;28(5):1381-1387 [PMID: 30857927]
  22. Environ Health Prev Med. 2011 Sep;16(5):307-12 [PMID: 21431788]
  23. Atherosclerosis. 2000 Jan;148(1):131-9 [PMID: 10580179]
  24. J Cereb Blood Flow Metab. 2007 Jan;27(1):14-20 [PMID: 16596120]
  25. World J Gastroenterol. 2009 Jan 28;15(4):457-61 [PMID: 19152450]
  26. Stroke. 2006 Jun;37(6):1503-7 [PMID: 16675740]
  27. QJM. 2002 Oct;95(10):691-3 [PMID: 12324642]
  28. Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1921-9 [PMID: 26342044]
  29. Diabetes Care. 2011 Jan;34(1):126-8 [PMID: 20921214]
  30. Stroke. 2003 Aug;34(8):1951-6 [PMID: 12843346]
  31. Stroke. 2002 Apr;33(4):1048-52 [PMID: 11935059]
  32. J Intensive Care Med. 2013 Mar-Apr;28(2):118-23 [PMID: 22337709]
  33. Circ J. 2007 Jul;71(7):1120-7 [PMID: 17587721]

Word Cloud

Created with Highcharts 10.0.0UAlevelsμmol/LICHin-hospitalseveritystrokemortalityassociationadmissionoutcomespatientscomplicationsdischargedisposition277210354Q1<0uricacidintracerebralhemorrhageexplorestudyChinaStrokeCenterAlliancePatientsfourgroupsincludedsignificantevidenceHowevercomparedhighersevereAmongpneumoniapoorswallowfunctiongastrointestinalbleedingDVTeffectprognosisspontaneousremainscontroversialaimedenrolledCSCAdividedQ1-Q4accordingquartilesprimaryoutcomesecondaryMultivariatelogisticregressionadopted84304acutefinalanalysismedianinterquartilerangedefinedfollows:Q2Q3Q4>indicatingcorrelateddecreasedoddsNIHSS16OR8995%CI86-092L-shapedfounddecreasedeepveinthrombosissignificantlyassociated0001protectivefactorindicatedpredictiveUricAcidClinicalOutcomesIntracerebralHemorrhagePatients:Resultscomplication

Similar Articles

Cited By